LET for Fibromyalgia

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

January 31, 2027

Conditions
Fibromyalgia
Interventions
DEVICE

Lymphatic Enhancement Technology (LET)

Lymphatic Enhancement Technology (LET) is an FDA-approved electrotherapeutic modality, with indications for addressing local lymphatic and vascular circulation as well as muscle pain and spasm. The Aria LET Elite Instrument (Arcturus Star, Cortez, Colorado) will be utilized for the intervention group.

DEVICE

Sham Lymphatic Enhancement Technology (LET)

A separate modified Aria Elite LET Instrument (Arcturus Star, Cortez, Colorado) will be utilized for the sham group. The sham LET device used for the control group will emit a light and sound similar to the true LET device, but will not emit energy waves.

Trial Locations (1)

75390

UT Southwestern Medical Center in the Allied Health Physical Therapy Clinic, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Arcturus Star Products

UNKNOWN

lead

University of Texas Southwestern Medical Center

OTHER